Crypto · IPO · Market Intelligence

Clear Signals for Market Momentum

Track IPOs, private companies, and crypto-related market movements in one modern intelligence platform.

Explore Data

Ambarella Prices Nasdaq IPO, Raises $36 Million for Video Chip Expansion

Date:

Ambarella (Nasdaq: AMBA), a fabless semiconductor company specializing in chips for high-definition video capture, completed its Nasdaq IPO on October 9, 2012, raising $36 million. Shares advanced modestly on debut, posting a +1.0% first-day return.

Company Overview

Founded in 2004 and headquartered in Santa Clara, California, Ambarella designs and develops low-power, high-definition video compression and image processing semiconductors. Its chips are widely used in cameras, video capture devices, and security systems, and have been integrated into consumer electronics, professional video equipment, and automotive applications. At the time of its IPO, the company employed 425 people.

IPO Details

  • IPO Date: October 9, 2012

  • Deal Size: $36 million

  • Offer Price & Shares: Not disclosed (IPO Intelligence Only)

  • Lead Underwriters: Confidential (IPO Intelligence Only)

  • Ticker Symbol: AMBA (Nasdaq)

Market Position

Ambarella entered public markets at a time of surging demand for HD video and streaming solutions, coinciding with the boom in connected devices and early adoption of wearable cameras. By leveraging its fabless model, the company reduced manufacturing costs while focusing on R&D and design innovation.

Looking Ahead

With IPO proceeds, Ambarella aimed to expand its product portfolio and solidify its position as a key player in the semiconductor industry for video processing, a sector expected to benefit from growing demand in consumer electronics, automotive safety, and surveillance markets.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

SHARE POST

Subscribe

Popular

More like this
Related

SKN | Sensing4D AI Files for $35 Million US IPO to Expand 3D Vision Technology

Sensing4D AI, a China-based provider of artificial intelligence-powered 3D...

SKN | IPO Momentum | U.S. IPO Calendar Expands as Nine Offerings Target October 21

Key Takeaways: Nine expected IPO pricings were listed for...

SKN | Lycia Therapeutics Sets Terms for $250 Million IPO to Advance Protein-Degrading Therapies

Lycia Therapeutics, a clinical-stage biotechnology company developing protein-degrading therapies...

SKN | Spyre Therapeutics Shares Surge 7.88% Ahead of November Earnings Report

Spyre Therapeutics, Inc. (NASDAQ: SYRE) shares rose 7.88% to...